ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Naratuximab Biosimilar - Anti-CD37 Antibody (Biotin) (A332003)

Recombinant chimeric monoclonal antibody to CD37 (Biotin) for Flow Cytometry.

Alternative Formats and ConjugatesAlternative Formats

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Naratuximab Biosimilar - Anti-CD37 Antibody (Biotin)
Description
Recombinant chimeric monoclonal antibody to CD37 (Biotin).
Applications
Flow Cytometry
Dilutions
Flow Cytometry: 1:100
Reactivity
Human
Host
Chimeric
Clonality
Monoclonal
Isotype
IgG1
Conjugate

Biotin

Purification
Affinity chromatography.
Concentration
Reconstitution dependent.
Product Form
Lyophilized
Reconstitution
Reconstitute with distilled sterile water.
Formulation
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
General Notes
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
Synonyms
Leukocyte antigen CD37, Tetraspanin-26, Tspan-26, TSPAN26
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Naratuximab Biosimilar - Anti-CD37 Antibody (Biotin) (A332003)? Please let us know so that we can list the citation on this page.

Alternative products to Naratuximab Biosimilar - Anti-CD37 Antibody (Biotin) (A332003)

Proteins predicted to interact with CD37

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
93.4% Relevancy Score
89.9% Relevancy Score
81.1% Relevancy Score
79.6% Relevancy Score
78.7% Relevancy Score
76.3% Relevancy Score
74.6% Relevancy Score
73.1% Relevancy Score